Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$17.3B
sum of reported positions
Reported positions
354
Changes vs prior quarter
395
84 new · 85 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 396 measured positions in 8 quarters, the typical new or larger position finished −3.9 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 985K | $470M | 2.7% | |
| 6.85M | $322M | 1.9% | |
| 959K | $321M | 1.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $13.6B | $17.3B |
| Positions | 355 | 354 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 3% |
| 4.42M |
| $267M |
| 1.5% |
| 786K | $262M | 1.5% |
| 2.8M | $249M | 1.4% |
Crinetics Pharmaceuticals Inc | 6.46M | $242M | 1.4% |
Apogee Therapeutics Inc | 1.74M | $231M | 1.3% |
| 1.53M | $230M | 1.3% |
| 6.72M | $223M | 1.3% |
| 557K | $217M | 1.3% |
| 4.73M | $192M | 1.1% |
| 497K | $189M | 1.1% |
| 1.31M | $187M | 1.1% |
| 229K | $174M | 1.0% |
| 1.77M | $171M | 1.0% |
| 6.16M | $152M | 0.9% |
| 4.43M | $148M | 0.9% |
| 1.21M | $144M | 0.8% |
| 1.56M | $142M | 0.8% |
| 517K | $141M | 0.8% |
| 227K | $140M | 0.8% |
| 4.83M | $140M | 0.8% |
| 1.99M | $138M | 0.8% |
| 355K | $134M | 0.8% |
Celldex Therapeutics (CLDX)
989K shares
Fuelcell Energy (FCEL)
1.01M shares
Target Hospitality (TH)
1.68M shares
Legend Biotech (LEGN)
1.16M shares
Lear (LEA)
249K shares
Mayville Engineering Company (MEC)
846K shares
Generac (GNRC)
105K shares
Innodata (INOD)
404K shares
Twilio (TWLO)
142K shares
Blacksky Technology (BKSY)
1.03M shares
Applied Aerospace & Defense (AADX)
1.23M shares
Madison Air Solutions (MAIR)
679K shares
Hemab Therapeutics Holdings (COAG)
716K shares
BorgWarner (BWA)
393K shares
Entravision Communications (EVC)
1.91M shares
Select Water Solutions (WTTR)
1.16M shares
Aehr Test Systems (AEHR)
238K shares
Whitefiber (WYFI)
582K shares
Arxis (ARXS)
481K shares
J.B. Hunt (JBHT)
74K shares
Evercore (EVR)
63K shares
MGM Resorts (MGM)
445K shares
RXO, Inc. (RXO)
769K shares
Century Aluminum Company (CENX)
456K shares
BJ's Restaurants, Inc. (BJRI)
317K shares
